SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Provectus Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: LurkeyTurkey who wrote (11402)7/2/2012 1:33:14 PM
From: jm2i1231 Recommendation  Read Replies (1) | Respond to of 13111
 
SPA : 3$ to 4$
nasdaq listing: 4 to 5$
derm deal: 5 to 8$
oncology partnership: 10$
oncology acquisition: 12-15$
total end game: 20-50$



To: LurkeyTurkey who wrote (11402)7/2/2012 3:39:41 PM
From: LT2011  Read Replies (1) | Respond to of 13111
 
Interesting that you are concerned about a pop in price if the company receives a SPA and then it quickly retreats. This has been on my mind for awhile and is one of the reasons why I want to hear all sides from all posters. I want to know the difference between real momentum and short term momentum.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News